Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Generation of a cost-effective cell line for support of high-throughput isolation of primary human B cells and monoclonal neutralizing antibodies

Journal of Immunological Methods(2020)10.1016/j.jim.2020.112901Source: DataRank Database

Generation of a cost-effective cell line for support of high-throughput isolation of primary human B cells and monoclonal neutralizing antibodies is a research paper published in Journal of Immunological Methods (2020). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (24)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Sarah Ameny,Tanvi Arkatkar ORCID,Aaron Seese ORCID,Abigail Wall ORCID,Iram Khan ORCID

Live enrichment

PubMed:33069767

National Institutes of Health

Grant: R01AI147846

National Institutes of Health

Grant: 5UM1AI068618

National Institutes of Health

Grant: UM1AI14462

National Institutes of Health

Grant: 5R01AI147846-02

Defining the protective efficacy of antibodies against the EBV gH/gL glycoprotein complex

National Institutes of Health

Grant: 3UM1AI068618-16S1

HVTN 405/HPTN 1901 (CoVPN) Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals: LC 3

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7560121

publisherhttps://api.elsevier.com/content/article/PII:S0022175920301952?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022175920301952?httpAccept=text/plain

https://doi.org/10.1016/j.jim.2020.112901

https://pubmed.ncbi.nlm.nih.gov/33069767

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

AdultB-LymphocytesAdolescentAntibodies, MonoclonalFeeder CellsCell DifferentiationEnzyme-Linked Immunosorbent Assay3T3 CellsCell SeparationAntibodies, ViralAntibodies, NeutralizingArticleCoculture TechniquesHigh-Throughput Screening AssaysMiceImmunogenicity, VaccineImmunoglobulin GAnimalsHumansFemaleCell Proliferation

Sustainable Development Goals

SDG 3: 3. Good health